Company intelligence / Profile preview

Axela Biosensors

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Axela was a Toronto-based biotechnology company specializing in the development of multiplexed molecular diagnostic platforms. The company's proprietary Diffractive Optics Technology (dot™) allowed for the real-time, label-free detection of protein and nucleic acid interactions. Axela's product portfolio included the Ziplex System, an automated workstation for gene expression profiling, and the dotLab System for protein analysis. These tools were primarily utilized in clinical research for biomarker discovery and validation, particularly in oncology and infectious diseases.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Device
Industry: Molecular Diagnostics

Partnerships

Xceed Molecular

Beyond the preview

Go deeper on Axela Biosensors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axela Biosensors.

Explore the full profile